These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 18776976

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Off-label use and the spectre of drug-eluting stent thrombosis.
    Cook S, Wenaweser P.
    Circ Cardiovasc Interv; 2009 Aug; 2(4):273-6. PubMed ID: 20031728
    [No Abstract] [Full Text] [Related]

  • 3. Effects of diabetes mellitus on platelet reactivity after dual antiplatelet therapy with aspirin and clopidogrel.
    van Werkum JW, Topcu Y, Postma S, Kelder JC, Hackeng CM, ten Berg JM, Verheugt FW.
    Thromb Haemost; 2008 Mar; 99(3):637-9. PubMed ID: 18327417
    [No Abstract] [Full Text] [Related]

  • 4. Noncardiac surgery after coronary stenting or angioplasty [corrected] .
    Tan WA.
    Catheter Cardiovasc Interv; 2009 Nov 15; 74(6):844-5. PubMed ID: 19902506
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.
    Wang ZJ, Zhou YJ, Liu YY, Yu M, Shi DM, Zhao YX, Guo YH, Cheng WJ, Jia de A, Cao Z, Nie B, Ge HL, Yang SW, Yan ZX.
    Thromb Res; 2009 May 15; 124(1):46-51. PubMed ID: 19041120
    [Abstract] [Full Text] [Related]

  • 9. Impact of "nuisance" bleeding on clopidogrel compliance in patients undergoing intracoronary drug-eluting stent implantation.
    Roy P, Bonello L, Torguson R, de Labriolle A, Lemesle G, Slottow TL, Steinberg DH, Kaneshige K, Xue Z, Satler LF, Kent KM, Suddath WO, Pichard AD, Lindsay J, Waksman R.
    Am J Cardiol; 2008 Dec 15; 102(12):1614-7. PubMed ID: 19064014
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Improving outcomes with antiplatelet therapies in percutaneous coronary intervention and stenting.
    Hobson A, Curzen N.
    Thromb Haemost; 2009 Jan 15; 101(1):23-30. PubMed ID: 19132185
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Multivessel disease in diabetics: does DES level the field?
    Hillegass W.
    Catheter Cardiovasc Interv; 2009 Jun 01; 73(7):881-2. PubMed ID: 19455651
    [No Abstract] [Full Text] [Related]

  • 14. SES for AMI: moving in the right direction.
    Vetrovec GW.
    Catheter Cardiovasc Interv; 2009 Aug 01; 74(2):333-4. PubMed ID: 19642181
    [No Abstract] [Full Text] [Related]

  • 15. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
    Mehilli J, Kastrati A, Byrne RA, Bruskina O, Iijima R, Schulz S, Pache J, Seyfarth M, Massberg S, Laugwitz KL, Dirschinger J, Schömig A, LEFT-MAIN Intracoronary Stenting and Angiographic Results: Drug-Eluting Stents for Unprotected Coronary Left Main Lesions Study Investigators.
    J Am Coll Cardiol; 2009 May 12; 53(19):1760-8. PubMed ID: 19422982
    [Abstract] [Full Text] [Related]

  • 16. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
    Prescrire Int; 2009 Oct 12; 18(103):193-5. PubMed ID: 19877380
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.